Skip to main content
News

Greenleaf: “Strong future” for Maryland biotech MDbizMedia

By March 28, 2012No Comments
NewImage

NewImagePeter Greenleaf

Peter Greenleaf visited the Department of Business and Economic Development recently to oversee the historic tax credit auction that raised $84 million for the state’s InvestMaryland program. Greenleaf took some time out from his duties as chairman of the Maryland Venture Fund Authority for a quick Q&A about his day job — running MedImmune, one of Maryland’s most successful life sciences companies.

{iframe}http://mdbizmedia.choosemaryland.org/2012/03/28/greenleaf-strong-future-for-maryland-biotech-and-life-sciences/{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.